AKT1 and cancer: Their activity is dependent on each other.23 Conventional cancer therapies, including chemotherapy and radiotherapy, could not completely prevail overexpression and activation of the PI3K/Akt pathway in cancer cells.24,25 To overcome drug resistance and side effects of traditional cancer therapies, application of various small molecule inhibitors could increase the specificity and efficacy of cancer targeting.